New Liver Biomarkers for diagnosis of common liver diseases

FibroTest and FibroMax are non-invasive, quick and reliable tests, validated by numerous studies in the most common liver injuries caused by Hepatitis B (1), Hepatitis C (2), metabolic disorders (3) and alcohol abuse (4), by only using a simple blood sample.

An alarming risk of fibrosis worldwide

Chronic liver disease is responsible for over 1.4million deaths annually (WHO, World Health Report 2004) and in the US is among the top ten disease related causes of death (CDC, National Center for Health Statistics, 2004).

Statistical analysis estimated that about 1.700 billion people worldwide present with risk factor of developing liver fibrosis:

  • About 300 million with fibrosis risk due to viral hepatitis B
  • About 180 million with fibrosis risk due to viral hepatitis C
  • About 600 million with fibrosis risk due to metabolic disorders (ex: overweight, obesity, cholesterol, type II diabetes…)
  • About 600 million with fibrosis risk due to excessive alcohol consumption

One of the most studied causes of liver fibrosis is the viral hepatitis C. The report on this disease is quiet alarming. Around 80% of the HCV infected patients remain undiagnosed in Europe and the US.

The impact of this lack of diagnosis is that HCV is responsible for 40% of liver cirrhosis, 60% of liver cancers and 40% of Liver transplants.


Glossary

  • (2) HCV: is a blood-borne infectious disease that is caused by Hepatitis C virus (HCV) infecting the liver.
  • (2) HBV: is a blood-borne infectious disease that is caused by Hepatitis B virus (HBV) infecting the liver.
  • (3) NASH (NAFLD): Nonalcoholic steatohepatitis is a common, often 'silent' liver disease featured by excessive fat in the liver associated with inflammation due to metabolic disorders like overweight/obesity, cholesterol, diabetes, hypertension' - (NAFLD: Non-Alcoholic Fatty Liver Disease)
  • (4) ASH (AFLD): Alcoholic steatohepatitis is caused by drinking too much alcohol which develop significant inflammation of the liver (ALD: Alcoholic liver disease)

     
  Interesting links
“Dr. Joe Galati's Blog on Liver Health”
“Learn about hepatitis”
“Learn about Hepatitis B”
“Learn about Hepatitis C”
“Learn about fatty liver”
“Learn about Clinical trials in the US”
“Learn about anti-fibrotic herbal solutions”




New Hope for Interferon Non-responders
Fifty percent of North Americans do not respond to the most utilized western medical treatment -- Interferon combination therapy. When a doctor says they've done all they can, and you are still sick, don't give up hope. You can still take steps to protect and support your liver. And, if you have not yet been treated by your doctor, consider Sho-saiko-to as a way to help keep your liver healthy.


Sho-saiko-to is a proven traditional liver remedy that has been prescribed to more than 1.5 million liver patients in Japan.